CAS No. |
208993-54-8 |
中文名称 |
3-(4-((3aR,9bR)-9-甲氧基-1,3a,4,9b-四氢色烯并[3,4-c]吡咯-2(3H)-基)丁基)-8-苯基吡嗪并[2',3':4,5]噻吩并[3,2-d]嘧啶-2,4(1H,3H)-二酮 |
英文名称 |
3-(4-((3AR,9bR)-9-methoxy-1,3a,4,9b-tetrahydrochromeno[3,4-c]pyrrol-2(3H)-yl)butyl)-8-phenylpyrazino[2',3':4,5]thieno[3,2-d]pyrimidine-2,4(1H,3H)-dione |
别名 |
Fiduxosin;3-[4-[(3aR,9bR)-9-methoxy-3,3a,4,9b-tetrahydro-1H-chromeno[3,4-c]pyrrol-2-yl]butyl]-8-phenyl-1H-pyrazino[1,2]thieno[3,4-b]pyrimidine-2,4-dione;Pyrazino[2',3':4,5]thieno[3,2-d]pyrimidine-2,4(1H,3H)-dione, 8-phenyl-3-[4-[(3aR,9bR)-1,3a,4,9b-tetrahydro-9-methoxy[1]benzopyrano[3,4-c]pyrrol-2(3H)-yl]butyl]- |
标准英文名 |
3-(4-((3aR,9bR)-9-methoxy-1,3a,4,9b-tetrahydrochromeno[3,4-c]pyrrol-2(3H)-yl)butyl)-8-phenylpyrazino[2',3':4,5]thieno[3,2-d]pyrimidine-2,4(1H,3H)-dione |
分子式 |
C30H29N5O4S |
分子量 |
555.66
|
精确分子量 |
555.19
|
SMILES |
O=C1N(CCCCN2C[C@@]3(COC4=CC=CC(OC)=C4[C@@]3(C2)[H])[H])C(NC5=C1SC6=NC=C(N=C56)C7=CC=CC=C7)=O |
标准SMILES |
COC1C=CC=C2OC[C@H]3CN(CCCCN4C(=O)NC5=C(SC6=NC=C(N=C56)C5C=CC=CC=5)C4=O)C[C@H]3C=12 |
用途 |
Fiduxosin is used as an α1-adrenoceptor antagonist for the treatment of conditions such as benign prostatic hyperplasia (BPH), based on its potent antagonism of α1a-adrenoceptors in the prostate and urethra, leading to reduced intraurethral pressure; it shows greater efficacy in blocking prostatic intraurethral pressure (IUP) responses compared to effects on mean arterial pressure (MAP), indicating uroselectivity. |
InChIKey |
WDTAYDBPNYFWDR-WOJBJXKFSA-N |